×
Customize
?
Start
Cancer Types
Quick Links
Award Programs
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873
Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873
Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
Maintenance therapy with defactinib failed to improve survival following front-line chemotherapy in patients with merlin-low malignant pleural mesothelioma, according to results from the phase 2 COMMAND trial.
Kristie L. Kahl
A novel imaging test developed at UT Southwestern may help to determine which patients with kidney cancer would benefit from treatment with immunotherapy.
Katie Kosko
Autoimmune skin toxicities in patients with non-small cell lung cancer mean patients may responds better to immune checkpoint inhibitors.
More
Voices
Martha Carlson
Getting back up matters when cancer knocks you down, but so does pausing for reflection.
Laura Yeager
As a cancer survivor, I am always on my toes.
Bonnie Annis
Should patients be given a choice on how they wish to receive bad news? One survivor seems to think so.
More
CURE Connections®
After elucidating their current status, Nancy and Dan MacMillan provide parting advice to patients and caregivers who encounter a diagnosis of small cell lung cancer.
Thinking of their journey through small cell lung cancer, Nancy and Dan MacMillan shed light on the support and information they found useful.
Nancy and Dan MacMillan reflect on Nancy’s diagnosis of small cell lung cancer and the treatment she received thereafter.
More
Videos
Ellen Miller-Sonet
With so many cancer treatment options now available, clinicians may still fall short in understanding what’s important to patients.
Dr. Reem Karmali
Maintenance therapy with Imbruvica appeared to be a feasible option for patients with mantle cell lymphoma, according to Dr. Reem Karmali.
Sue Friedman, DVM
Sue Friedman, founder and executive director of FORCE, discussed how a breast cancer diagnosis at age 33 and a family history of cancer led to the creation of Facing Our Risk of Cancer Empowered.
More
Podcasts
Katie Kosko
In this week’s episode of the “CURE® Talks Cancer” podcast, we spoke with a caregiver who found hope in the darkness after losing her son to lung cancer at just 29 years old.
Kristie L. Kahl
In this week’s episode, we spoke with a patient and his doctor about genomic testing and how it can change treatment outcomes for patients with cancer.
Kristie L. Kahl
In this episode of “CURE Talks Cancer,” we spoke with a patient, an advocate and a doctor to learn more about bladder cancer and what others should know about the disease.
More
